Viromed Medical AG (ETR:VME)
Germany flag Germany · Delayed Price · Currency is EUR
6.50
0.00 (0.00%)
Last updated: Aug 26, 2026, 9:18 AM CET

Viromed Medical AG Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.095.091.12---
Revenue Growth
110.43%352.27%----
Gross Profit
2.292.29-0.29---
Operating Income
-0.83-0.83-3.5-0.36-0.16-0.01
Net Income
0.60.6-3.09-0.11-0.16-0.01
Earnings Per Share
0.030.03-0.15-0.01-0.01-
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.360.360.020.20.150.25
Total Debt
0.010.010.01---
Net Cash (Debt)
0.360.360.010.20.150.25
Net Cash Growth
158.36%2637.35%-93.35%29.78%-39.04%-
Net Cash Per Share
0.020.020.000.010.01-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
44.92%44.92%-25.60%---
Operating Margin
-16.23%-16.23%-311.14%---
Pretax Margin
-13.62%-13.62%-365.97%---
Profit Margin
11.88%11.88%-274.95%---

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
228.50127.29----
PS Ratio
27.1515.1344.65---